Company: GIFLF
Filing Date: 2025-02-26
Form Type: 6-K
Source: 0001104659-25-017501
Chunk: 31

Company: Grifols SA
Filing Date: 2025-02-26
Form: 6-K
Chunk 31
---
4 2023 % Var Reported Net Revenues 7,212,382 6,591,977 9.4% Variation due to Exchange Rate Effects 58,550 Net Revenues at Constant Currency 7,270,932 6,591,977 10.3% In thousands of euros 2024 2023 % Var Reported Biopharma Net Revenues 6,142,586 5,558,301 10.5% Variation due to Exchange Rate Effects 45,143 Reported Biopharma Net Revenues at Constant Currency 6,187,729 5,558,301 11.3% In thousands of euros 2024 2023 % Var Reported Diagnostic Net Revenues 644,898 670,269 (3.8%) Variation due to Exchange Rate Effects 11,360 Reported Diagnostic Net Revenues at Constant Currency 656,258 670,269 (2.1%) In thousands of euros 2024 2023 % Var Reported Bio Supplies Net Revenues 215,666 159,957 34.8% Variation due to Exchange Rate Effects 753 Reported Bio Supplies Net Revenues at Constant Currency 216,419 159,957 35.3% In thousands of euros 2024 2023 % Var Reported Others & Intersegments Net Revenues 209,232 203,450 2.8% Variation due to Exchange Rate Effects 1,294 Reported Other & Intersegments Net Revenues at Constant Currency 210,526 203,450 3.5% In thousands of euros 2024 2023 % Var Reported U.S. + Canada Net Revenues 4,087,030 3,898,961 4.8% Variation due to Exchange Rate Effects 30,222 Reported U.S. + Canada Net Revenues at Constant Currency 4,117,252 3,898,961 5.6% In thousands of euros 2024 2023 % Var Reported EU Net Revenues 1,498,898 1,255,927 19.3% Variation due to Exchange Rate Effects 125 Reported EU Net Revenues at Constant Currency 1,499,023 1,255,927 19.4% In thousands of euros 2024 2023 % Var Reported ROW Net Revenues 1,626,455 1,437,089 13.2% Variation due to Exchange Rate Effects 28,202 Reported ROW